AACR Annual Meeting 2026 Presidential Sessions Explore Cancer Interception and Prevention
At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...
Tag: Cancer interception
At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...
At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people...
In the CAR-PRISM clinical trial, the CAR T-cell therapy ciltacabtagene autoleucel showed promise for treating high-risk smoldering myeloma.
Injecting immunotherapy directly into precancerous oral lesions may be an effective way to prevent progression to cancer without surgery.
Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
For June 2025, the editors of AACR's journals highlighted studies on pancreatic cancer interception, breast cancer risk prediction, and...
Experts discussed "Discovery Science in Early Cancer Biology and Interception" at a plenary during the AACR Annual Meeting 2024.